Free Services  

  • MONITOR KEYWORDS
  • Enter keywords & we'll notify you when a new patent matches your request (weekly update).

  • ORGANIZER
  • Save & organize patents so you can view them later.

  • ARCHIVE
  • View the last few months of your Keyword emails.

  • COMPANY DIRECTORY
  • Patents sorted by company.

Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
NextPrevious

Pyrazine compounds as phosphodiesterase 10 inhibitors




Title: Pyrazine compounds as phosphodiesterase 10 inhibitors.
Abstract: or a pharmaceutically acceptable salt thereof, wherein m, n, p, R1, R2, R3, R4, X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, Y and Z are defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like. Pyrazine compounds of formula (I): ...


Browse recent Amgen Inc. patents


USPTO Applicaton #: #20120277209
Inventors: Jennifer R. Allen, Matthew P. Bourbeau, Ning Chen, Essa Hu, Roxanne Kunz, Shannon Rumfelt


The Patent Description & Claims data below is from USPTO Patent Application 20120277209, Pyrazine compounds as phosphodiesterase 10 inhibitors.




← Previous       Next → Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Pyrazine compounds as phosphodiesterase 10 inhibitors patent application.
###
monitor keywords


Browse recent Amgen Inc. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Pyrazine compounds as phosphodiesterase 10 inhibitors or other areas of interest.
###


Previous Patent Application:
Novel heterocyclic acrylamides and their use as pharmaceuticals
Next Patent Application:
Reverse transcriptase inhibitors
Industry Class:
Drug, bio-affecting and body treating compositions
Thank you for viewing the Pyrazine compounds as phosphodiesterase 10 inhibitors patent info.
- - -

Results in 0.04205 seconds


Other interesting Freshpatents.com categories:
Computers:  Graphics I/O Processors Dyn. Storage Static Storage Printers

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-0.4631

66.232.115.224
Next →
← Previous

stats Patent Info
Application #
US 20120277209 A1
Publish Date
11/01/2012
Document #
File Date
12/31/1969
USPTO Class
Other USPTO Classes
International Class
/
Drawings
0




Follow us on Twitter
twitter icon@FreshPatents

Amgen Inc.


Browse recent Amgen Inc. patents



Drug, Bio-affecting And Body Treating Compositions   Designated Organic Active Ingredient Containing (doai)   Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai   Hetero Ring Is Four-membered And Includes At Least One Ring Nitrogen   Having -c(=x)-, Wherein X Is Chalcogen, Bonded Directly To The Four-membered Hetero Ring   Additional Hetero Ring Attached Directly Or Indirectly To The Four-membered Hetero Ring By Nonionic Bonding  

Browse patents:
Next →
← Previous
20121101|20120277209|pyrazine compounds as phosphodiesterase 10 inhibitors|or a pharmaceutically acceptable salt thereof, wherein m, n, p, R1, R2, R3, R4, X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, Y and Z are defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating |Amgen-Inc